Malignant neoplasm of liver, not specified as primary or secondary
- C22.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Malig neoplasm of liver, not specified as primary or sec
- The 2024 edition of ICD-10-CM C22.9 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C22.9 – other international versions of ICD-10 C22.9 may differ.
The following code(s) above C22.9 contain annotation back-references
that may be applicable to C22.9:
- C00-D49 Neoplasms
- C15-C26 Malignant neoplasms of digestive organs
- C22 Malignant neoplasm of liver and intrahepatic bile ducts
Approximate Synonyms
- Cancer of the liver
- Malignant neoplasm of liver
Clinical Information
- Your liver is the largest organ inside your body. It filters harmful substances from the blood, digests fats from food and stores the sugar that your body uses for energy. Primary liver cancer starts in the liver. Metastatic liver cancer starts somewhere else and spreads to your liver. Risk factors for primary liver cancer include
- having hepatitis
- having cirrhosis, or scarring of liver
- being male
- low weight at birth
ICD-10-CM C22.9 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 435 Malignancy of hepatobiliary system or pancreas with mcc
- 436 Malignancy of hepatobiliary system or pancreas with cc
- 437 Malignancy of hepatobiliary system or pancreas without cc/mcc
Convert C22.9 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change